Andrews Institute for Orthopaedics & Sports Medicine and the Andrews Research & Education Foundation are facilitating a randomized, multi-center Phase II U.S. FDA-observed clinical trial evaluating use of a patient’s own stem cells to regenerate knee cartilage.
This is reportedly the first time that stem cells will be evaluated in a clinical trial for the ability to regenerate cartilage in massive knee cartilage injuries. The 6-year study may end early if results indicate statistical significance.
The study seeks to replicate outcomes from clinical treatments currently available to patients in Malaysia, and is partially funded by the Malaysian government.
Andrews Institute for Orthopaedics & Sports Medicine and the Andrews Research & Education Foundation are facilitating a randomized, multi-center Phase II U.S. FDA-observed clinical trial evaluating use of a patient's own stem cells to regenerate knee cartilage.
This is reportedly the first time that stem cells will be evaluated in a...
Andrews Institute for Orthopaedics & Sports Medicine and the Andrews Research & Education Foundation are facilitating a randomized, multi-center Phase II U.S. FDA-observed clinical trial evaluating use of a patient’s own stem cells to regenerate knee cartilage.
This is reportedly the first time that stem cells will be evaluated in a clinical trial for the ability to regenerate cartilage in massive knee cartilage injuries. The 6-year study may end early if results indicate statistical significance.
The study seeks to replicate outcomes from clinical treatments currently available to patients in Malaysia, and is partially funded by the Malaysian government.
Copy to clipboard 
